MedAvail Holdings, Inc.

MDVLQ · OTC
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Revenue$405$620$11,350$11,461
% Growth-34.7%-94.5%-1%
Cost of Goods Sold$227$363$11,476$11,549
Gross Profit$178$257-$126-$88
% Margin44%41.5%-1.1%-0.8%
R&D Expenses$145$176$163$178
G&A Expenses$4,422$5,047$7,542$0
SG&A Expenses$4,432$5,067$7,689$11,225
Sales & Mktg Exp.$10$20$147$0
Other Operating Expenses$55$0$0$0
Operating Expenses$4,632$5,268$10,618$11,403
Operating Income-$4,454-$5,011-$10,744-$11,491
% Margin-1,099.8%-808.2%-94.7%-100.3%
Other Income/Exp. Net-$1,042-$7,547-$326-$315
Pre-Tax Income-$5,496-$12,558-$11,070-$11,806
Tax Expense$0$0$0$0
Net Income-$5,791-$17,330-$11,070-$11,806
% Margin-1,429.9%-2,795.2%-97.5%-103%
EPS-3.22-10.79-6.91-7.37
% Growth70.2%-56.2%6.2%
EPS Diluted-3.22-10.79-6.91-7.37
Weighted Avg Shares Out1,7981,6051,6021,601
Weighted Avg Shares Out Dil1,7981,6051,6021,601
Supplemental Information
Interest Income$0$1$1$0
Interest Expense$146$169$327$315
Depreciation & Amortization$431$884$1,623$1,805
EBITDA-$4,919-$11,505-$9,120-$9,686
% Margin-1,214.6%-1,855.6%-80.4%-84.5%